Company profile: Cellartis
1.1 - Company Overview
Company description
- Provider of biotechnology, based in Sweden.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cellartis
Cardea Bio
HQ: United States
Website
- Description: Provider of graphene-based, biology-gated transistor infrastructure and biosensing solutions, including: BPU Platform converting biological interactions into electrical signals for real-time multiomics; graphene biosensors for direct biomolecule measurement; CRISPR-Chip for gene editing efficiency; and commercial/research partnerships across healthcare, agriculture, and environmental monitoring.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cardea Bio company profile →
Univercells Technologies
HQ: Belgium
Website
- Description: Provider of biomanufacturing services and platforms for cost-effective viral production from R&D to commercial scale, offering scale-X bioreactors (hydro, carbo) for adherent and suspension cells, the scale-X cell collect system, and the NevoLine Upstream platform integrating virus production, concentration, and clarification, plus services including equipment confirmation, capacity and facility design, and bioprocess excellence.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Univercells Technologies company profile →
BioAffinity Technologies
HQ: United States
Website
- Description: Provider of non-invasive, early-stage cancer diagnostics, including CyPath® Lung, a sputum-based lung cancer test analyzed via flow cytometry and machine learning. Through Precision Pathology Laboratory Services, offers laboratory services and provides CyPath® Lung as a Laboratory Developed Test. Also conducts R&D to expand porphyrin-based platform technologies for targeted cancer diagnostics and therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioAffinity Technologies company profile →
Mission Bio
HQ: United States
Website
- Description: Provider of a single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development, offering the Tapestri Platform for DNA and protein analysis to detect rare clonal populations, custom assay development, single-cell analysis services for therapeutic development, and sample multiplexing to increase throughput and reduce costs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mission Bio company profile →
Lightspeed Genomics
HQ: United States
Website
- Description: Provider of a high-speed DNA sequencing platform enabling faster, lower-cost human genome sequencing. The technology supports innovation in basic research, drug development, and medical diagnostics, driving advances in healthcare.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lightspeed Genomics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cellartis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cellartis
2.2 - Growth funds investing in similar companies to Cellartis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cellartis
4.2 - Public trading comparable groups for Cellartis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →